FDA Clears Roche cobas eplex RP3 Respiratory Test Panel
The Roche cobas eplex RP3 identifies up to 19 viral and bacterial pathogens in under two hours, giving healthcare teams flexible diagnostic options.
The Roche cobas eplex RP3 identifies up to 19 viral and bacterial pathogens in under two hours, giving healthcare teams flexible diagnostic options.
The Roche cobas eplex RP3 identifies up to 19 viral and bacterial pathogens in under two hours, giving healthcare teams flexible diagnostic options.
Read MoreNew RNA extraction techniques overcome barriers to help scientists better evaluate treatments for diseases such as pulmonary fibrosis.
Read MoreDistinct lipid signatures identified in blood plasma and exhaled breath samples can differentiate between IPF and fibrotic hypersensitivity pneumonitis.
Read MoreOnly about 18% of eligible US adults underwent lung cancer screening in 2022, lagging far behind rates for breast and colorectal cancer screenings.
Read MoreMedibyt’s CPETWise automated platform aims to cut cardiopulmonary exercise testing interpretation time in half and standardize clinical workflows.
Read MoreCo-Diagnostics submitted a dual 510(k) premarket notification and CLIA Waiver by Application to the FDA for its Co-Dx PCR Flu A/B & RSV multiplex respiratory test.
Read MoreWearable stickers can accurately measure sweat chloride levels in cystic fibrosis patients in under an hour without specialized laboratory equipment.
Read MoreProAxsis and Imperial College London are investigating the NEATstik test, which detects active neutrophil elastase (NE) in sputum samples.
Read MoreRT looks at some of the latest simulation technology available from IMT Analytics, Michigan Instruments and South Pacific Biomedical.
Read MoreA closer look as some of the latest spirometers and PFT devices on the market from Jaeger Medical, MGC Diagnostics, Vitalograph, and VacuMed.
Read MoreA TB blood test identifies a bacterial marker to distinguish between active and latent tuberculosis infections.
Read MoreZepto Life Technology has introduced FungiFlex Pneumocystis jirovecii and the FungiFlex Mold Plus Panel testing assays.
Read MoreA study of more than 570,000 people validates a polygenic risk score to identify idiopathic pulmonary fibrosis patients at risk for severe outcomes or death.
Read MoreCryocision flexible cryocatheter system is the first console-free and wholly single-use flexible cryosurgical system for bronchoscopic applications available in the US and Canada.
Read MoreThe AMDI Fast PCR System provides point-of-care results for RSV, influenza, and COVID-19 in less than 10 minutes.
Read MoreThe liquid biopsy panel identifies fungal DNA in plasma to help clinicians diagnose life-threatening infections in immunocompromised patients.
Read MoreHackensack Meridian Pascack Valley Medical Center successfully completed its first endobronchial ultrasound to diagnose pulmonary conditions.
Read MoreThe ecosystem integrates two diagnostic levels into one patient record to help physicians personalize sleep apnea diagnostics and monitoring.
Read MoreA new analysis shows that early use of rapid testing for bloodstream infections reduces sepsis progression and healthcare expenses.
Read MoreA new visual Ai agent aims to reduce subjectivity and improve documentation efficiency for clinicians performing skin prick testing.
Read MoreThe new Roche diagnostic test identifies 25 viruses and bacteria to help clinicians provide...
Read MoreOn World Tuberculosis Day, March 24, a test developed by UC Davis Health could soon speed up diagnosis and help prevent its spread.
Read MoreUntargeted metagenomic sequencing detected previously missed respiratory viruses in about 5% of samples that had tested negative on standard NAAT panels.
Read MoreRecent funding has allowed Children’s Hospital of Chicago’s Primary Ciliary Dyskinesia Center to purchase its first Long Read Sequencing (LRS) machine to aid PCD genetic testing.
Read More